4.6 Article

The entomopathogenic fungus Beauveria bassiana and its compatibility with triflumuron:: effects on the twospotted spider mite Tetranychus urticae

Journal

BIOLOGICAL CONTROL
Volume 26, Issue 2, Pages 168-173

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S1049-9644(02)00123-8

Keywords

entomopathogenic fungus; Beauveria bassiana; spider mite; Tetranychus urticae; triflumuron; benzoylphenyl ureas; compatibility

Ask authors/readers for more resources

Laboratory studies were conducted to determine the effects of the mycoinsecticide Naturalis-L (Beanveria bassiana conidial formulation) on the twospotted spider mite Tetranychus urticae. Compatibility of B. bassiana with triflumuron (benzoylphenyl urea typically used as an insecticide, but also with acaricide effects), was also investigated in order to incorporate both in the control of this pest. For each juvenile stage, 180-22,800 viable conidia/mL on deutonymphs, 380-12,160 viable conidia/mL on protonymphs, and 712-7480 viable conidia/mL on larvae were evaluated. For the adult stage, the concentrations ranged from 213 to 54,720 viable conidia/mL. The mortality data used in the analysis were those accumulated after 5 days of treatment for deutonymphs and protonymphs, 7 days for larvae and 9 days for adults. The lethal concentration to kill 50% (LC50) for the juvenile stages was 3184 viable conidia/mL (their probit-log concentration regression lines were the same), and 1949 viable conidia/mL for adults. No significant differences in mortality were observed among egg age classes (24-, 48-, 72-, and 96-h-old eggs) at the tested concentrations (1400-22,800 viable conidia/mL). When B. bassiana was combined with 0.25 g Alsystin (25% triflumuron as a wettable powder)/L, mite egg mortality decreased significantly. Triflumuron reduced mycelial growth but not conidial germination of B. bassiana. This fungus is a possible candidate to be included in integrated pest management programs with triflumuron of T urticae. In such programs, the possible antagonist effects of triflumuron should be considered. (C) 2002 Elsevier Science (USA). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available